We are live on ! Find out more
TCON

TRACON Pharmaceuticals

Delisted

TCON was delisted on the 27th of June, 2024.

20 hedge funds and large institutions have $46.3M invested in TRACON Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more capital inflows, than outflows

Capital inflows: $3.61M | Capital outflows: $1.49M

1.61% more ownership

Funds ownership: 33.24% → 34.86% (+1.6%)

5% less funds holding

Funds holding: 21 → 20 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TCON Hedge Fund Activity: Q2 2015 in Review

20 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in TRACON Pharmaceuticals (TCON) for Q2 2015, worth a combined $46.3M — down 18% from $56.3M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TCON and 7 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, opening a new position worth an estimated $239K. The largest seller was Millennium Management, exiting entirely with an estimated $372K sold.

  • 20 institutional investors held TRACON Pharmaceuticals (TCON) as of Q2 2015, down from 21 in Q1 2015.
  • Funds reported $46.3M of TRACON Pharmaceuticals stock for Q2 2015, down 18% quarter-over-quarter.
  • 7 funds opened new TRACON Pharmaceuticals positions in Q2 2015 and 8 closed out, a net change of -1 holder.
  • The largest TRACON Pharmaceuticals buyer in Q2 2015 was Vanguard Group, an estimated $239K added.
  • The largest TRACON Pharmaceuticals seller in Q2 2015 was Millennium Management, an estimated $372K sold.

Based on aggregated 13F filings for Q2 2015.